Skip to main content
Top
Published in: Critical Care 3/2010

Open Access 01-06-2010 | Research

Costs of relaparotomy on-demand versus planned relaparotomy in patients with severe peritonitis: an economic evaluation within a randomized controlled trial

Authors: Brent C Opmeer, Kimberly R Boer, Oddeke van Ruler, Johannes B Reitsma, Hein G Gooszen, Peter W de Graaf, Bas Lamme, Michael F Gerhards, E Philip Steller, Cecilia M Mahler, Huug Obertop, Dirk J Gouma, Patrick MM Bossuyt, Corianne AJM de Borgie, Marja A Boermeester

Published in: Critical Care | Issue 3/2010

Login to get access

Abstract

Introduction

Results of the first randomized trial comparing on-demand versus planned-relaparotomy strategy in patients with severe peritonitis (RELAP trial) indicated no clear differences in primary outcomes. We now report the full economic evaluation for this trial, including detailed methods, nonmedical costs, further differentiated cost calculations, and robustness of different assumptions in sensitivity analyses.

Methods

An economic evaluation was conducted from a societal perspective alongside a randomized controlled trial in 229 patients with severe secondary peritonitis and an acute physiology and chronic health evaluation (APACHE)-II score ≥11 from two academic and five regional teaching hospitals in the Netherlands. After the index laparotomy, patients were randomly allocated to an on-demand or a planned-relaparotomy strategy. Primary resource-utilization data were used to estimate mean total costs per patient during the index admission and after discharge until 1 year after the index operation. Overall differences in costs between the on-demand relaparotomy strategy and the planned strategy, as well as relative differences across several clinical subgroups, were evaluated.

Results

Costs were substantially lower in the on-demand group (mean, €65,768 versus €83,450 per patient in the planned group; mean absolute difference, €17,682; 95% CI, €5,062 to €29,004). Relative differences in mean total costs per patient (approximately 21%) were robust to various alternative assumptions. Planned relaparotomy consistently generated more costs across the whole range of different courses of disease (quick recovery and few resources used on one end of the spectrum; slow recovery and many resources used on the other end). This difference in costs between the two surgical strategies also did not vary significantly across several clinical subgroups.

Conclusions

The reduction in societal costs renders the on-demand strategy a more-efficient relaparotomy strategy in patients with severe peritonitis. These differences were found across the full range of healthcare resources as well as across patients with different courses of disease.

Trial Registration

ISRCTN51729393
Appendix
Available only for authorised users
Literature
1.
go back to reference Christou NV, Barie PS, Dellinger EP, Waymack JP, Stone HH: Surgical Infection Society intra-abdominal infection study: prospective evaluation of management techniques and outcome. Arch Surg 1993, 128: 193-198.CrossRefPubMed Christou NV, Barie PS, Dellinger EP, Waymack JP, Stone HH: Surgical Infection Society intra-abdominal infection study: prospective evaluation of management techniques and outcome. Arch Surg 1993, 128: 193-198.CrossRefPubMed
2.
go back to reference Koperna T, Schulz F: Prognosis and treatment of peritonitis: do we need new scoring systems? Arch Surg 1996, 131: 180-186.CrossRefPubMed Koperna T, Schulz F: Prognosis and treatment of peritonitis: do we need new scoring systems? Arch Surg 1996, 131: 180-186.CrossRefPubMed
3.
go back to reference Lamme B, Boermeester MA, Belt EJ, van Till JW, Gouma DJ, Obertop H: Mortality and morbidity of planned relaparotomy versus relaparotomy on demand for secondary peritonitis. Br J Surg 2004, 91: 1046-1054. 10.1002/bjs.4517CrossRefPubMed Lamme B, Boermeester MA, Belt EJ, van Till JW, Gouma DJ, Obertop H: Mortality and morbidity of planned relaparotomy versus relaparotomy on demand for secondary peritonitis. Br J Surg 2004, 91: 1046-1054. 10.1002/bjs.4517CrossRefPubMed
5.
go back to reference Anaya DA, Nathens AB: Risk factors for severe sepsis in secondary peritonitis. Surg Infect (Larchmt ) 2003, 4: 355-362. 10.1089/109629603322761418CrossRef Anaya DA, Nathens AB: Risk factors for severe sepsis in secondary peritonitis. Surg Infect (Larchmt ) 2003, 4: 355-362. 10.1089/109629603322761418CrossRef
6.
go back to reference van Ruler O, Mahler CW, Boer KR, Reuland EA, Gooszen HG, Opmeer BC, de Graaf PW, Lamme B, Gerhards MF, Steller EP, van Till JW, de Borgie CJ, Gouma DJ, Reitsma JB, Boermeester MA, Dutch Peritonitis Study Group: Comparison of on-demand vs planned relaparotomy strategy in patients with severe peritonitis: a randomized trial. JAMA 2007, 298: 865-872. 10.1001/jama.298.8.865CrossRefPubMed van Ruler O, Mahler CW, Boer KR, Reuland EA, Gooszen HG, Opmeer BC, de Graaf PW, Lamme B, Gerhards MF, Steller EP, van Till JW, de Borgie CJ, Gouma DJ, Reitsma JB, Boermeester MA, Dutch Peritonitis Study Group: Comparison of on-demand vs planned relaparotomy strategy in patients with severe peritonitis: a randomized trial. JAMA 2007, 298: 865-872. 10.1001/jama.298.8.865CrossRefPubMed
7.
go back to reference Knaus WA, Harrell FE Jr, Lynn J, Goldman L, Phillips RS, Connors AF Jr, Dawson NV, Fulkerson WJ Jr, Califf RM, Desbiens N, Layde P, Oye RK, Bellamy PE, Hakim RB, Wagner DP: The SUPPORT prognostic model: objective estimates of survival for seriously ill hospitalized adults: study to understand prognoses and preferences for outcomes and risks of treatments. Ann Intern Med 1995, 122: 191-203.CrossRefPubMed Knaus WA, Harrell FE Jr, Lynn J, Goldman L, Phillips RS, Connors AF Jr, Dawson NV, Fulkerson WJ Jr, Califf RM, Desbiens N, Layde P, Oye RK, Bellamy PE, Hakim RB, Wagner DP: The SUPPORT prognostic model: objective estimates of survival for seriously ill hospitalized adults: study to understand prognoses and preferences for outcomes and risks of treatments. Ann Intern Med 1995, 122: 191-203.CrossRefPubMed
8.
go back to reference Bohnen JM, Mustard RA, Oxholm SE, Schouten BD: APACHE II score and abdominal sepsis: a prospective study. Arch Surg 1988, 123: 225-229.CrossRefPubMed Bohnen JM, Mustard RA, Oxholm SE, Schouten BD: APACHE II score and abdominal sepsis: a prospective study. Arch Surg 1988, 123: 225-229.CrossRefPubMed
9.
go back to reference Gold MR, Siegel JE, Russel LB: Cost-effectiveness in Health and Medicine. New York: Oxford University Press; 1996. Gold MR, Siegel JE, Russel LB: Cost-effectiveness in Health and Medicine. New York: Oxford University Press; 1996.
10.
go back to reference Edbrooke D, Hibbert C, Ridley S, Long T, Dickie H: The development of a method for comparative costing of individual intensive care units: The Intensive Care Working Group on Costing. Anaesthesia 1999, 54: 110-120. 10.1046/j.1365-2044.1999.00650.xCrossRefPubMed Edbrooke D, Hibbert C, Ridley S, Long T, Dickie H: The development of a method for comparative costing of individual intensive care units: The Intensive Care Working Group on Costing. Anaesthesia 1999, 54: 110-120. 10.1046/j.1365-2044.1999.00650.xCrossRefPubMed
11.
go back to reference Riteco JA, Heij LJ, Luijn JC, Wolff I: Richtlijnen voor farmaco-economisch onderzoek [Guidelines for pharmaco-economic research]. Amstelveen: College voor Zorgverzekeringen (CvZ) [Health Insurance Board]; 1999. Riteco JA, Heij LJ, Luijn JC, Wolff I: Richtlijnen voor farmaco-economisch onderzoek [Guidelines for pharmaco-economic research]. Amstelveen: College voor Zorgverzekeringen (CvZ) [Health Insurance Board]; 1999.
12.
go back to reference Oostenbrink JB, Koopmanschap MA, Rutten FF: Standardisation of costs: the Dutch Manual for Costing in economic evaluations. Pharmacoeconomics 2002, 20: 443-454. 10.2165/00019053-200220070-00002CrossRefPubMed Oostenbrink JB, Koopmanschap MA, Rutten FF: Standardisation of costs: the Dutch Manual for Costing in economic evaluations. Pharmacoeconomics 2002, 20: 443-454. 10.2165/00019053-200220070-00002CrossRefPubMed
13.
go back to reference van Roijen L, Essink-Bot ML, Koopmanschap MA, Bonsel G, Rutten FF: Labor and health status in economic evaluation of health care: The Health and Labor Questionnaire. Int J Technol Assess Health Care 1996, 12: 405-415.CrossRefPubMed van Roijen L, Essink-Bot ML, Koopmanschap MA, Bonsel G, Rutten FF: Labor and health status in economic evaluation of health care: The Health and Labor Questionnaire. Int J Technol Assess Health Care 1996, 12: 405-415.CrossRefPubMed
14.
go back to reference Oostenbrink JB, Buijs-Van der WT, van AM, Koopmanschap MA, Rutten FF: Unit costs of inpatient hospital days. Pharmacoeconomics 2003, 21: 263-271. 10.2165/00019053-200321040-00004CrossRefPubMed Oostenbrink JB, Buijs-Van der WT, van AM, Koopmanschap MA, Rutten FF: Unit costs of inpatient hospital days. Pharmacoeconomics 2003, 21: 263-271. 10.2165/00019053-200321040-00004CrossRefPubMed
15.
go back to reference Van der Kuy A: Farmacotherapeutisch Kompas 2000/2001 [Pharmacotherapeutic Compass 2000/2001]. Amstelveen: College voor zorgverzekeringen (CvZ) [Health Insurance Board]; 2000. Van der Kuy A: Farmacotherapeutisch Kompas 2000/2001 [Pharmacotherapeutic Compass 2000/2001]. Amstelveen: College voor zorgverzekeringen (CvZ) [Health Insurance Board]; 2000.
16.
go back to reference Huiskes LG: Tarieflijst instellingen 2001 [Tariff list institutions 2001]. College Tarieven Gezondheidszorg (CTG) [National Health Tariffs Authority]; 2000. Huiskes LG: Tarieflijst instellingen 2001 [Tariff list institutions 2001]. College Tarieven Gezondheidszorg (CTG) [National Health Tariffs Authority]; 2000.
18.
go back to reference Ramsey S, Willke R, Briggs A, Brown R, Buxton M, Chawla A, Cook J, Glick H, Liljas B, Petitti D, Reed S: Good research practices for cost-effectiveness analysis alongside clinical trials: The ISPOR RCT-CEA task force report. Value Health 2005, 8: 521-533. 10.1111/j.1524-4733.2005.00045.xCrossRefPubMed Ramsey S, Willke R, Briggs A, Brown R, Buxton M, Chawla A, Cook J, Glick H, Liljas B, Petitti D, Reed S: Good research practices for cost-effectiveness analysis alongside clinical trials: The ISPOR RCT-CEA task force report. Value Health 2005, 8: 521-533. 10.1111/j.1524-4733.2005.00045.xCrossRefPubMed
19.
go back to reference Koperna T: Cost-effectiveness of defunctioning stomas in low anterior resections for rectal cancer: a call for benchmarking. Arch Surg 2003, 138: 1334-1338. 10.1001/archsurg.138.12.1334CrossRefPubMed Koperna T: Cost-effectiveness of defunctioning stomas in low anterior resections for rectal cancer: a call for benchmarking. Arch Surg 2003, 138: 1334-1338. 10.1001/archsurg.138.12.1334CrossRefPubMed
20.
go back to reference Sznajder M, Aegerter P, Launois R, Merliere Y, Guidet B, CubRea : A cost-effectiveness analysis of stays in intensive care units. Intensive Care Med 2001, 27: 146-153. 10.1007/s001340000760CrossRefPubMed Sznajder M, Aegerter P, Launois R, Merliere Y, Guidet B, CubRea : A cost-effectiveness analysis of stays in intensive care units. Intensive Care Med 2001, 27: 146-153. 10.1007/s001340000760CrossRefPubMed
21.
go back to reference Heyland DK, Konopad E, Noseworthy TW, Johnston R, Gafni A: Is it 'worthwhile' to continue treating patients with a prolonged stay (>14 days) in the ICU? An economic evaluation. Chest 1998, 114: 192-198. 10.1378/chest.114.1.192CrossRefPubMed Heyland DK, Konopad E, Noseworthy TW, Johnston R, Gafni A: Is it 'worthwhile' to continue treating patients with a prolonged stay (>14 days) in the ICU? An economic evaluation. Chest 1998, 114: 192-198. 10.1378/chest.114.1.192CrossRefPubMed
22.
go back to reference Moerer O, Schmid A, Hofmann M, Herklotz A, Reinhart K, Werdan K, Schneider H, Burchardi H: Direct costs of severe sepsis in three German intensive care units based on retrospective electronic patient record analysis of resource use. Intensive Care Med 2002, 28: 1440-1446. 10.1007/s00134-002-1429-9CrossRefPubMed Moerer O, Schmid A, Hofmann M, Herklotz A, Reinhart K, Werdan K, Schneider H, Burchardi H: Direct costs of severe sepsis in three German intensive care units based on retrospective electronic patient record analysis of resource use. Intensive Care Med 2002, 28: 1440-1446. 10.1007/s00134-002-1429-9CrossRefPubMed
24.
go back to reference Hau T, Ohmann C, Wolmershauser A, Wacha H, Yang Q: Planned relaparotomy vs relaparotomy on demand in the treatment of intra-abdominal infections: The Peritonitis Study Group of the Surgical Infection Society-Europe. Arch Surg 1995, 130: 1193-1196.CrossRefPubMed Hau T, Ohmann C, Wolmershauser A, Wacha H, Yang Q: Planned relaparotomy vs relaparotomy on demand in the treatment of intra-abdominal infections: The Peritonitis Study Group of the Surgical Infection Society-Europe. Arch Surg 1995, 130: 1193-1196.CrossRefPubMed
25.
go back to reference Lamme B, Boermeester MA, Reitsma JB, Mahler CW, Obertop H, Gouma DJ: Meta-analysis of relaparotomy for secondary peritonitis. Br J Surg 2002, 89: 1516-1524. 10.1046/j.1365-2168.2002.02293.xCrossRefPubMed Lamme B, Boermeester MA, Reitsma JB, Mahler CW, Obertop H, Gouma DJ: Meta-analysis of relaparotomy for secondary peritonitis. Br J Surg 2002, 89: 1516-1524. 10.1046/j.1365-2168.2002.02293.xCrossRefPubMed
26.
go back to reference Lamme B, Boermeester MA, de VR, van RO, van Till JW, Obertop H: Survey among surgeons on surgical treatment strategies for secondary peritonitis. Dig Surg 2003, 21: 387-395. 10.1159/000081883CrossRefPubMed Lamme B, Boermeester MA, de VR, van RO, van Till JW, Obertop H: Survey among surgeons on surgical treatment strategies for secondary peritonitis. Dig Surg 2003, 21: 387-395. 10.1159/000081883CrossRefPubMed
27.
go back to reference van Goor H, Hulsebos RG, Bleichrodt RP: Complications of planned relaparotomy in patients with severe general peritonitis. Eur J Surg 1997, 163: 61-66.PubMed van Goor H, Hulsebos RG, Bleichrodt RP: Complications of planned relaparotomy in patients with severe general peritonitis. Eur J Surg 1997, 163: 61-66.PubMed
28.
go back to reference Wacha H, Linder MM, Feldmann U, Wesch G, Gundlach E, Steifensand RA: Mannheim Peritonitis Index: prediction of risk of death from peritonitis: construction of a statistical and validation of an emperically based index. Theor Surg 1987, 2: 169-177. Wacha H, Linder MM, Feldmann U, Wesch G, Gundlach E, Steifensand RA: Mannheim Peritonitis Index: prediction of risk of death from peritonitis: construction of a statistical and validation of an emperically based index. Theor Surg 1987, 2: 169-177.
29.
go back to reference Giesbers H: Beddencapaciteit ziekenhuizen. In Volksgezondheid Toekomst Verkenning, Nationale Atlas Volksgezondheid. Bilthoven: RIVM; 2003. Giesbers H: Beddencapaciteit ziekenhuizen. In Volksgezondheid Toekomst Verkenning, Nationale Atlas Volksgezondheid. Bilthoven: RIVM; 2003.
Metadata
Title
Costs of relaparotomy on-demand versus planned relaparotomy in patients with severe peritonitis: an economic evaluation within a randomized controlled trial
Authors
Brent C Opmeer
Kimberly R Boer
Oddeke van Ruler
Johannes B Reitsma
Hein G Gooszen
Peter W de Graaf
Bas Lamme
Michael F Gerhards
E Philip Steller
Cecilia M Mahler
Huug Obertop
Dirk J Gouma
Patrick MM Bossuyt
Corianne AJM de Borgie
Marja A Boermeester
Publication date
01-06-2010
Publisher
BioMed Central
Published in
Critical Care / Issue 3/2010
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc9032

Other articles of this Issue 3/2010

Critical Care 3/2010 Go to the issue